The latest board meeting for Cytek BioSciences Inc took place on 14 Jan 2026, for the purpose of 44th Annual J.P. Morgan Healthcare ConferenceSee details
Cytek BioSciences Inc has a share price target of US$ 6, revenue growth forecast of -1.8%, and profit growth estimate of -352.5% for FY25, based on top 5 analyst calls.